Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Solesence (SLSN) Common Equity (2016 - 2025)

Solesence's Common Equity history spans 16 years, with the latest figure at $17.6 million for Q4 2025.

  • For Q4 2025, Common Equity rose 17.98% year-over-year to $17.6 million; the TTM value through Dec 2025 reached $17.6 million, up 17.98%, while the annual FY2025 figure was $17.6 million, 17.98% up from the prior year.
  • Common Equity reached $17.6 million in Q4 2025 per SLSN's latest filing, up from $17.2 million in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $18.2 million in Q2 2025 to a low of $1.9 million in Q4 2023.
  • Average Common Equity over 5 years is $9.3 million, with a median of $7.6 million recorded in 2021.
  • Peak YoY movement for Common Equity: tumbled 66.33% in 2023, then surged 685.8% in 2024.
  • A 5-year view of Common Equity shows it stood at $7.5 million in 2021, then fell by 24.33% to $5.6 million in 2022, then plummeted by 66.33% to $1.9 million in 2023, then soared by 685.8% to $14.9 million in 2024, then rose by 17.98% to $17.6 million in 2025.
  • Per Business Quant, the three most recent readings for SLSN's Common Equity are $17.6 million (Q4 2025), $17.2 million (Q3 2025), and $18.2 million (Q2 2025).